Should I buy or sell Microbot Medical stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBOT shares. View MBOT analyst ratings or view top-rated stocks .

What is Microbot Medical's stock price target for 2024?

1 brokerages have issued 1 year target prices for Microbot Medical's shares. Their MBOT share price targets range from $8.00 to $8.00. On average, they predict the company's share price to reach $8.00 in the next year. This suggests a possible upside of 676.7% from the stock's current price. View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts .

How have MBOT shares performed in 2024?

Microbot Medical's stock was trading at $1.64 at the start of the year. Since then, MBOT stock has decreased by 37.2% and is now trading at $1.03. View the best growth stocks for 2024 here .

Are investors shorting Microbot Medical?

Microbot Medical saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 173,300 shares, an increase of 93.4% from the March 15th total of 89,600 shares. Based on an average daily trading volume, of 100,600 shares, the days-to-cover ratio is presently 1.7 days. View Microbot Medical's Short Interest .

When is Microbot Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024. View our MBOT earnings forecast .

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) announced its quarterly earnings results on Monday, November, 15th. The biotechnology company reported ($0.36) EPS for the quarter, hitting analysts' consensus estimates of ($0.36).

When did Microbot Medical's stock split?

Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include Advanced Micro Devices (AMD) , Athersys (ATHX) , NVIDIA (NVDA) , Gilead Sciences (GILD) , Inovio Pharmaceuticals (INO) , Novavax (NVAX) , Pfizer (PFE) , Micron Technology (MU) and Sorrento Therapeutics (SRNE) .

How do I buy shares of Microbot Medical?

Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:MBOT

Microbot Medical (MBOT) Stock Price, News & Analysis

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Free MBOT Stock Alerts

$1.03

+0.02 (+1.98%)

(As of 04/15/2024 ET)

Compare

Today's Range: $1.01
▼
$1.10
50-Day Range: $1.01
▼
$1.34
52-Week Range: $1.00
▼
$4.37

Volume: 179,779 shs
Average Volume: 120,096 shs
Market Capitalization: $14.83 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $8.00

Get Microbot Medical alerts:

Microbot Medical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 676.7% Upside
$8.00 Price Target
Short Interest: Healthy
1.20% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.37
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.55 out of 5 stars

Medical Sector

716th out of 929 stocks

Surgical & Medical Instruments Industry

75th out of 97 stocks

3.5

Analyst's Opinion

Consensus Rating
Microbot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Microbot Medical has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.20% of the outstanding shares of Microbot Medical have been sold short.
Short Interest Ratio / Days to Cover
Microbot Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Microbot Medical has recently increased by 93.42%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Microbot Medical does not currently pay a dividend.
Dividend Growth
Microbot Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MBOT.

2.4

News and Social Media Coverage

News Sentiment
Microbot Medical has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Microbot Medical this week, compared to 1 article on an average week.
Search Interest
8 people have searched for MBOT on MarketBeat in the last 30 days.
MarketBeat Follows
Only 2 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Microbot Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
10.64% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 16.30% of the stock of Microbot Medical is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Microbot Medical is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Microbot Medical is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Microbot Medical has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Microbot Medical Stock (NASDAQ:MBOT)

Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. In addition, it provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

MBOT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MBOT Stock News Headlines

April 15, 2024 | globenewswire.com

Microbot Medical Shares Status Following Recent Geopolitical Events

April 12, 2024 | americanbankingnews.com

Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Update

April 16, 2024 | Porter & Company (Ad)

The #1 Investment of the Decade…

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

April 9, 2024 | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) & Alpha Tau Medical (NASDAQ:DRTS) Financial Analysis

March 28, 2024 | msn.com

3 AI Stocks Wall Street Expects to Return Up to 595% in 2024

March 27, 2024 | investorplace.com

MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023

March 16, 2024 | ca.finance.yahoo.com

MBOT Apr 2024 3.000 call

February 26, 2024 | benzinga.com

Microbot Medical Stock (NASDAQ:MBOT) Dividends: History, Yield and Dates

April 16, 2024 | Porter & Company (Ad)

The #1 Investment of the Decade…

February 21, 2024 | finance.yahoo.com

MBOT Jul 2024 2.500 put

February 21, 2024 | finance.yahoo.com

MBOT Apr 2024 5.000 call

February 18, 2024 | finance.yahoo.com

MBOT Mar 2024 2.500 call

February 5, 2024 | finanznachrichten.de

Microbot Medical Inc.: Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

February 5, 2024 | msn.com

Microbot files FDA application for clinical study of Liberty system

February 5, 2024 | finance.yahoo.com

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

February 2, 2024 | benzinga.com

Looking Into Microbot Medical's Recent Short Interest

January 31, 2024 | msn.com

Microbot Medical Settles: Regulation FD Disclosure Update

January 30, 2024 | finanznachrichten.de

Microbot Medical Inc.: Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

January 30, 2024 | msn.com

Microbot Medical announces settlement resolving legal matters

January 30, 2024 | finance.yahoo.com

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

January 18, 2024 | finance.yahoo.com

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

December 29, 2023 | marketwatch.com

Microbot Medical Shares Drop 20% After Exercising Investment Options

December 29, 2023 | msn.com

Gold Moves Lower; Microbot Medical Shares Slide

December 29, 2023 | msn.com

Microbot Medical down 22%, exercises investment options for $2.73M proceeds

December 29, 2023 | finance.yahoo.com

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

December 28, 2023 | msn.com

Microbot to advance Liberty Robotic System into pivotal clinical trial

December 28, 2023 | markets.businessinsider.com

Microbot Medical Announces Positive Results For GLP Pivotal Pre-Clinical Study; Stock Up 15%

See More Headlines

Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2021
Today: 4/16/2024
Next Earnings (Estimated): 5/15/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:MBOT
CUSIP: N/A
CIK: 883975
Web: www.microbotmedical.com
Phone: (781) 875-3605
Fax: 781-556-5347
Employees: 18
Year Founded: 2010

Price Target and Rating

Average Stock Price Target: $8.00
High Stock Price Target: $8.00
Low Stock Price Target: $8.00
Potential Upside/Downside: +676.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,740,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -164.13%
Return on Assets: -125.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.09
Quick Ratio: 2.09

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.38 per share
Price / Book: 2.71

Miscellaneous

Outstanding Shares: 14,400,000
Free Float: 12,867,000
Market Cap: $14.83 million
Optionable: Optionable
Beta: 1.64

Social Links

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Harel Gadot (Age 51)
Co-Founder, President, CEO & Chairman
Comp: $813.82k
Mr. Yoseph Bornstein (Age 65)
Co-Founder & Independent Director
Comp: $13.12k

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

MBOT Stock Analysis - Frequently Asked Questions

Should I buy or sell Microbot Medical stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBOT shares.
View MBOT analyst ratings or view top-rated stocks.
What is Microbot Medical's stock price target for 2024?: 1 brokerages have issued 1 year target prices for Microbot Medical's shares. Their MBOT share price targets range from $8.00 to $8.00. On average, they predict the company's share price to reach $8.00 in the next year. This suggests a possible upside of 676.7% from the stock's current price.
View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts.
How have MBOT shares performed in 2024?: Microbot Medical's stock was trading at $1.64 at the start of the year. Since then, MBOT stock has decreased by 37.2% and is now trading at $1.03.
View the best growth stocks for 2024 here.
Are investors shorting Microbot Medical?: Microbot Medical saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 173,300 shares, an increase of 93.4% from the March 15th total of 89,600 shares. Based on an average daily trading volume, of 100,600 shares, the days-to-cover ratio is presently 1.7 days.
View Microbot Medical's Short Interest.
When is Microbot Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024.
View our MBOT earnings forecast.

How were Microbot Medical's earnings last quarter?: Microbot Medical Inc. (NASDAQ:MBOT) announced its quarterly earnings results on Monday, November, 15th. The biotechnology company reported ($0.36) EPS for the quarter, hitting analysts' consensus estimates of ($0.36).
When did Microbot Medical's stock split?: Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.
What other stocks do shareholders of Microbot Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE).
How do I buy shares of Microbot Medical?: Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MBOT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial